368. A Phase 3, Randomized, Double-blind, Parallel-group Trial to Evaluate the Immunogenicity and Safety of AV7909 for Post-exposure Prophylaxis of Anthrax in Healthy Adults

BACKGROUND: This was intended as a pivotal safety and immunogenicity Phase 3 trial of AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) in healthy adults. AV7909 was developed for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis. METHODS: A Phase 3, ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Akintunde, Gideon, Drobic, Bojan, Bedell, Lisa, Gan, Lu, Kim, Julia, Beah, Marinda, Ghinai, Isaac, Collado, Santiago Barona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677431/
http://dx.doi.org/10.1093/ofid/ofad500.438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677431/
http://dx.doi.org/10.1093/ofid/ofad500.438

Ejemplares similares